Faculty profile

Anand Kumar

Back to faculty

ProfessorDepartment of Internal MedicineUniversity of Manitoba

Anand Kumar

Professor

Department of Internal Medicine

Max Rady College of Medicine

University of Manitoba

Winnipeg, Manitoba, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
11 publications in the last five years, latest in 2026.
Principal investigator on 2 research grants (2 CIHR), most recently in 2019.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

114

Publications

17,912

Citations

107

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Manitoba profile.

Septic shock

Latest papers

Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: a randomized clinical trial.
Journal of thrombosis and haemostasis : JTH · 2026
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections
New England Journal of Medicine · 2025
Society of Critical Care Medicine Guidelines on Recognizing and Responding to Clinical Deterioration Outside the ICU: 2023
Critical Care Medicine · 2024

All 114 publications

Latest funding

Best Effective Antibiotic Treatment for Community Acquired Pneumonia (BEAT-CAP): A pilot feasibility domain of the GUARD-Resp platform trial
CIHR · 2025 · Co-investigator
$180,000
Dexamethasone For Preventing Deterioration In Community Acquired Pneumonia (DEFEND-CAP)
CIHR · 2023 · Co-investigator
$1,375,000
Dexamethasone For Preventing Deterioration In Community Acquired Pneumonia (DEFEND-CAP)
CIHR · 2023 · Co-investigator
$5,500,001

All 19 grants and awards

114 publications.

Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: a randomized clinical trial.

Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia (REMAP-CAP) Investigators, Bradbury CA, McVerry BJ, Lawler PR, Angus DC, Annane D, Arabi YM, Aryal D, Au C, Beane A, Berry SM, Berry LR, Best-Lane J, Bihari S, Bonten M, Brunkhorst F, Burrell A, Buxton M, Carrier M, Cecconi M, Cheng AC, Cove M, Derde LPG, Detry MA, Estcourt LJ, Fergusson DA, Fitzgerald M, Fowler RA, Goligher EC, Green C, Haniffa R, Harrison DA, Hays LMC, Higgins AM, Hills T, Horvat CM, Huang DT, Hunt BJ, Ichihara N, Jayakumar D, Keattch S, Kumar A, Laffan MA, Lamontagne F, Leeper CM, Lewis RJ, Lorenzi E, Lother SA, Marshall JC, McArthur CJ, McAuley DF, McGlothlin A, McGuinness SP, McQuilten ZK, Middeldorp S, Morpeth S, Mouncey PR, Murthy S, Neal MD, Nichol AD, Parke RL, Parker JC, Peters S, Reyes LF, Rowan K, Saito H, Santos M, Saunders CT, Schutgens REG, Seymour CW, Hari MS, Singh V, Stanworth SJ, Turgeon AF, Turner AM, van de Veerdonk FL, Gordon AC, Webb SA, Zarychanski R

Journal of thrombosis and haemostasis : JTH2026

DOI: 10.1016/j.jtha.2026.03.006 PMID: 41895526

Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections

Daneman N, Rishu A, Pinto R, Rogers BA, Shehabi Y, Parke R, Cook D, Arabi Y, Muscedere J, Reynolds S

New England Journal of Medicine2025167 citations

DOI: 10.1056/nejmoa2404991

Society of Critical Care Medicine Guidelines on Recognizing and Responding to Clinical Deterioration Outside the ICU: 2023

Honarmand K, Wax RS, Penoyer D, Lighthall G, Danesh V, Rochwerg B, Cheatham ML, Davis DP, DeVita M, Downar J

Critical Care Medicine202457 citations

DOI: 10.1097/ccm.0000000000006072

Adjudication of Codes for Identifying Sepsis in Hospital Administrative Data by Expert Consensus*

Garland A, Li N, Sligl W, Lane A, Thavorn K, Wilcox ME, Rochwerg B, Keenan S, Marrie TJ, Kumar A

Critical Care Medicine202412 citations

DOI: 10.1097/ccm.0000000000006432

Executive Summary: Society of Critical Care Medicine Guidelines on Recognizing and Responding to Clinical Deterioration Outside the ICU

Honarmand K, Wax RS, Penoyer D, Lighthall G, Danesh V, Rochwerg B, Cheatham ML, Davis DP, DeVita M, Downar J

Critical Care Medicine20244 citations

DOI: 10.1097/ccm.0000000000006071

Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia.

Lee CH, Banoei MM, Ansari M, Cheng MP, Lamontagne F, Griesdale D, Lasry DE, Demir K, Dhingra V, Tran KC, Lee T, Burns K, Sweet D, Marshall J, Slutsky A, Murthy S, Singer J, Patrick DM, Lee TC, Boyd JH, Walley KR, Fowler R, Haljan G, Vinh DC, Mcgeer A, Maslove D, Mann P, Donohoe K, Hernandez G, Rocheleau G, Trahtemberg U, Kumar A, Lou M, Dos Santos C, Baker A, Russell JA, Winston BW, *ARBs CORONA I. Investigators

Critical care (London, England)2024

DOI: 10.1186/s13054-024-04843-0 PMID: 38414082

Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19.

Godoy LC, Neal MD, Goligher EC, Cushman M, Houston BL, Bradbury CA, McQuilten ZK, Tritschler T, Kahn SR, Berry LR, Lorenzi E, Jensen T, Higgins AM, Kornblith LZ, Berger JS, Gong MN, Paul JD, Castellucci LA, Le Gal G, Lother SA, Rosenson RS, Derde LPG, Kumar A, McVerry BJ, Nicolau JC, Leifer E, Escobedo J, Huang DT, Reynolds HR, Carrier M, Kim KS, Hunt BJ, Slutsky AS, Turgeon AF, Webb SA, McArthur CJ, Farkouh ME, Hochman JS, Zarychanski R, Lawler PR

JACC. Advances2024

DOI: 10.1016/j.jacadv.2023.100780 PMID: 38938844

Persistence of live virus in critically ill patients infected with SARS-COV-2: a prospective observational study

Funk DJ, Bullard J, Lother S, Grande GV, Garnett L, Doan K, Dust K, Kumar A, Poliquin G, Strong J

Critical Care202211 citations

DOI: 10.1186/s13054-021-03884-z

NFκB1 Polymorphisms Are Associated with Severe Influenza A (H1N1) Virus Infection in a Canadian Population.

Mirzo SM, Kumar A, Sharma NK, Li L, Balshaw R, Plummer FA, Luo M, Liang B

Microorganisms2022

DOI: 10.3390/microorganisms10101886 PMID: 36296162

White blood cell count trajectory and mortality in septic shock: a historical cohort study.

Rimmer E, Garland A, Kumar A, Doucette S, Houston BL, Menard CE, Leeies M, Turgeon AF, Mahmud S, Houston DS, Zarychanski R

Canadian journal of anaesthesia = Journal canadien d'anesthesie2022

DOI: 10.1007/s12630-022-02282-5 PMID: 35902458

Best Effective Antibiotic Treatment for Community Acquired Pneumonia (BEAT-CAP): A pilot feasibility domain of the GUARD-Resp platform trial

Co-investigatorCIHR2025Project Grant

Principal investigators: Lother, Sylvain

Keywords: Antibiotic; Pneumonia

$180,000

Dexamethasone For Preventing Deterioration In Community Acquired Pneumonia (DEFEND-CAP)

Co-investigatorCIHR2023Operating Grant: Clinical Trials Projects - Indirect Costs

Principal investigators: Zarychanski, Ryan; Lawler, Patrick R; Lother, Sylvain; McDonald, Emily G

Keywords: Bayesian Adaptive Trial; Community Acquired Pneumonia (Cap); Corticosteroids; Dexamethasone; Phase Iii Trial; Randomized Trial

$1,375,000

Dexamethasone For Preventing Deterioration In Community Acquired Pneumonia (DEFEND-CAP)

Co-investigatorCIHR2023Operating Grant: Clinical Trials Projects

Principal investigators: Zarychanski, Ryan; Lawler, Patrick R; Lother, Sylvain; McDonald, Emily G

Keywords: Bayesian Adaptive Trial; Community Acquired Pneumonia (Cap); Corticosteroids; Dexamethasone; Phase Iii Trial; Randomized Trial

$5,500,001

Therapeutic Plasma Exchange in Septic Shock (PLEXSIS): A Pilot Study

Co-investigatorCIHR2022Project Grant

Principal investigators: Rimmer, Emily; Zarychanski, Ryan

Keywords: Critical Care; Sepsis; Septic Shock; Therapeutic Apheresis

$307,530

BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections

Co-investigatorCIHR2022Operating Grant: Clinical Trials Projects - Indirect Costs

Principal investigators: Daneman, Nick; Murthy, Srinivas; Yamamura, Deborah L; Fowler, Robert A; Johnstone, Jennie; Lee, Todd C; MacFadden, Derek R; McDonald, Emily G; Paterson, David L; Rogers, Benjamin A; Yahav, Dafna

Keywords: Adaptive Platform Trial; Antibiotic De-Escalation; Antibiotic Step-Down; Antimicrobial Resistance; Bloodstream Infection; Central Venous Catheter Infection; Gram Negative Bacteremia; Randomized Controlled Trial

$729,947

Anti-Thrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia (ATTACC-CAP)

Co-investigatorCIHR2022Project Grant

Principal investigators: Zarychanski, Ryan; Lawler, Patrick R; Turgeon, Alexis F

Keywords: Community Acquired Pneumonia; Heparin; Randomized Trial; Therapeutic Anticoagulation

$3,961,936

BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections

Co-investigatorCIHR2022Operating Grant: Clinical Trials Projects

$2,919,785

ANTI-THROMBOTIC THERAPY TO AMELIORATE COMPLICATIONS OF COVID-19 (ATTACC): A randomized, international, multi-centre, adaptive, controlled clinical trial

Co-investigatorCIHR2020Operating Grant: COVID-19 Rapid Research Funding Opportunity - Therapeutics

Principal investigators: Zarychanski, Ryan; Escobedo, Jorge; Goligher, Ewan C; Lawler, Patrick R; Nicolau, Jose C

Keywords: Anti-Thrombotic; Bayesian Adaptive; Covid-19; Sepsis; Thrombosis

$3,573,336

Therapeutic Plasma Exchange in Septic Shock: A Pilot Study

Co-investigatorCIHR2020Project Grant - PA: Epigenetics/epigenomics in human health or disease

Principal investigators: Rimmer, Emily; Zarychanski, Ryan

Keywords: Critical Care; Sepsis; Septic Shock; Therapeutic Apheresis

$100,000

Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): A Randomized Controlled Clinical Trial

Co-investigatorCIHR2020Project Grant

Principal investigators: Daneman, Nick; Fowler, Robert A

Keywords: Antibiotic Treatment; Bacteremia; Critical Care / Intensive Care; Duration Of Therapy; Randomized Controlled Trial

$531,675

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Profile data last refreshed on September 27, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Anand Kumar

Research

Latest papers

Latest funding

Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: a randomized clinical trial.

Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections

Society of Critical Care Medicine Guidelines on Recognizing and Responding to Clinical Deterioration Outside the ICU: 2023

Adjudication of Codes for Identifying Sepsis in Hospital Administrative Data by Expert Consensus*

Executive Summary: Society of Critical Care Medicine Guidelines on Recognizing and Responding to Clinical Deterioration Outside the ICU

Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia.

Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19.

Persistence of live virus in critically ill patients infected with SARS-COV-2: a prospective observational study

NF&#x3ba;B1 Polymorphisms Are Associated with Severe Influenza A (H1N1) Virus Infection in a Canadian Population.

White blood cell count trajectory and mortality in septic shock: a historical cohort study.

Frequent collaborators

Ryan Zarychanski

Deborah Cook

Peter Dodek

Lauralyn McIntyre

Srinivas Murthy

Francois Lamontagne

Sangeeta Mehta

Emily Rimmer

John Marshall

Gloria Vazquez-Grande

John Muscedere

Bram Rochwerg

Nick Daneman

Marc Carrier

Ruxandra Pinto

Sylvain Lother

Yoav Keynan

Murdoch Leeies

Emilie Belley-Cote

François Lauzier

Darwyn Kobasa

Darryl Falzarano

Peter Lawrence Gross

Robert Fowler

Mansoor Husain

Alison Fox-Robichaud

Steven Theriault

Lisa Burry

Ma Luo

Simon Oczkowski

Jorge Escobedo

Derek Stein

Stephen Lapinsky

Juthaporn Cowan

Robert Kozak

John Marshall

Sean van Diepen

Rachel Rodin

Ewan Goligher

Peter Daley

NFκB1 Polymorphisms Are Associated with Severe Influenza A (H1N1) Virus Infection in a Canadian Population.